CAPLIN POINT LABORATORIES
Back to Balance Sheet
|
CAPLIN POINT LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹18 Cr | ₹0.64 Cr | ₹0.64 Cr | ₹0.64 Cr | ₹0.71 Cr |
What is the latest Contingent Liabilities ratio of CAPLIN POINT LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹18 Cr |
| Mar2025 | ₹0.64 Cr |
| Mar2024 | ₹0.64 Cr |
| Mar2023 | ₹0.64 Cr |
| Mar2022 | ₹0.71 Cr |
How is Contingent Liabilities of CAPLIN POINT LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹18 Cr | 2,639.06 | |
| Mar2025 | ₹0.64 Cr | 0.00 | |
| Mar2024 | ₹0.64 Cr | 0.00 | |
| Mar2023 | ₹0.64 Cr | -9.86 | |
| Mar2022 | ₹0.71 Cr | - | |
Compare Contingent Liabilities of peers of CAPLIN POINT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CAPLIN POINT LABORATORIES | ₹18,411.4 Cr | 4.2% | -9.6% | 19% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,963.0 Cr | 2.7% | 1.4% | 4.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹269,451.0 Cr | 4.5% | 6.3% | 50.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,456.0 Cr | 1.8% | -1.3% | 31.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,664.0 Cr | 0.8% | 12.5% | 14.1% | Stock Analytics | |
| CIPLA | ₹113,246.0 Cr | 1.6% | 4.4% | -9.1% | Stock Analytics | |
CAPLIN POINT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CAPLIN POINT LABORATORIES | 4.2% |
-9.6% |
19% |
| SENSEX | 7% |
9.6% |
-6.7% |
You may also like the below Video Courses